Dalia Mahmoud Eldewi1, Hanan A El-Hagrasy1, Rasha Mahmoud Gouda2, Mohammed Abd El Malik Hassan3, Shimaa Moustafa Kamel2, Naglaa F Abd El Haliem4, Haneya A A Anani4. 1. Department of Clinical Pathology - Faculty of Medicine (For Girls), Al‑Azhar University, Cairo, Egypt. 2. Department of Pediatric - Faculty of Medicine (For Girls), Al‑Azhar University, Cairo, Egypt. 3. Department of Pediatric - Faculty of Medicine (For Boys), Al‑Azhar University, Cairo, Egypt. 4. Departments of Medical Microbiology and Immunology Faculty of Medicine (For Girls), Al‑Azhar University, Cairo, Egypt.
Abstract
Background: Mature bone marrow T lymphocytes and NK may have a special relevance in the control of the malignant growth. Objective: We aimed to assess the percentage of the residual BM T-cells, (T-helper -T-cytotoxic- NKT) and the NK cells of childhood precursor B-lymphoblastic leukemia (B-ALL) as an indicator of innate and adaptive immunity in these patients. Subjects and Methods: This study was conducted on 40 B-ALL patients, and 40 apparently healthy matched children served as a control group. The flow cytometry was used to assess the percentage of the residual BM T-cells (T-helper, T-cytotoxic and NKT), and the NK cells. Results: Compared with the control group, the percentage of the residual BM T-cells, its subtypes (T-helper, T-cytotoxic), and NKT cells in addition to the NK cells was significantly decreased in Group IA, and Group IB, but there was no significant difference between Group IA and Group IB in all studied parameters. In terms of the CD4/CD8 ratio, there was a significant increase in Group IA as compared to the control group (P < 0.026), but there were no significant statistical differences in CD4/CD8 ratio between Groups IB, and the control. Likewise, in CD4/CD8 ratio between groups IA, and Groups IB (P > 0.05). The percentage of NK, and NKT cells shows a significant increase in Hepatomegaly and Splenomegaly, as compared to non-Hepatomegaly and non-Splenomegaly patients of Groups IB (P < 0.05). However, there was a significant increase in statistical differences in the percentage of NKT cell between non-Splenomegaly, as compared to Splenomegaly patients of Group IA (P < 0.05). Additionally, there is a negative correlation between B.M Blast% to CD4/CD8 ratio and NK%, but there is no significant correlation between B.M Blast% to NK T% in the group 1 A.
Background: Mature bone marrow T lymphocytes and NK may have a special relevance in the control of the malignant growth. Objective: We aimed to assess the percentage of the residual BM T-cells, (T-helper -T-cytotoxic- NKT) and the NK cells of childhood precursor B-lymphoblastic leukemia (B-ALL) as an indicator of innate and adaptive immunity in these patients. Subjects and Methods: This study was conducted on 40 B-ALL patients, and 40 apparently healthy matched children served as a control group. The flow cytometry was used to assess the percentage of the residual BM T-cells (T-helper, T-cytotoxic and NKT), and the NK cells. Results: Compared with the control group, the percentage of the residual BM T-cells, its subtypes (T-helper, T-cytotoxic), and NKT cells in addition to the NK cells was significantly decreased in Group IA, and Group IB, but there was no significant difference between Group IA and Group IB in all studied parameters. In terms of the CD4/CD8 ratio, there was a significant increase in Group IA as compared to the control group (P < 0.026), but there were no significant statistical differences in CD4/CD8 ratio between Groups IB, and the control. Likewise, in CD4/CD8 ratio between groups IA, and Groups IB (P > 0.05). The percentage of NK, and NKT cells shows a significant increase in Hepatomegaly and Splenomegaly, as compared to non-Hepatomegaly and non-Splenomegaly patients of Groups IB (P < 0.05). However, there was a significant increase in statistical differences in the percentage of NKT cell between non-Splenomegaly, as compared to Splenomegaly patients of Group IA (P < 0.05). Additionally, there is a negative correlation between B.M Blast% to CD4/CD8 ratio and NK%, but there is no significant correlation between B.M Blast% to NK T% in the group 1 A.
Authors: A G Bean; D I Godfrey; W G Ferlin; L Santos-Argumedo; M E Parkhouse; M C Howard; A Zlotnik Journal: Int Immunol Date: 1995-02 Impact factor: 4.823
Authors: K J Hammond; S B Pelikan; N Y Crowe; E Randle-Barrett; T Nakayama; M Taniguchi; M J Smyth; I R van Driel; R Scollay; A G Baxter; D I Godfrey Journal: Eur J Immunol Date: 1999-11 Impact factor: 5.532
Authors: Ahmed M Ismail; Said M Abdou; Hassan Abdel Aty; Adel H Kamhawy; Mohammed Elhinedy; Mohammed Elwageh; Atef Taha; Amal Ezzat; Hoda A Salem; Said Youssif; Mohamed L Salem Journal: Cytotechnology Date: 2014-12-16 Impact factor: 2.058
Authors: Eva Steliarova-Foucher; Murielle Colombet; Lynn A G Ries; Florencia Moreno; Anastasia Dolya; Freddie Bray; Peter Hesseling; Hee Young Shin; Charles A Stiller Journal: Lancet Oncol Date: 2017-04-11 Impact factor: 41.316
Authors: Lucero Valenzuela-Vazquez; Juan Carlos Núñez-Enríquez; Jacqueline Sánchez-Herrera; Elva Jiménez-Hernández; Jorge Alfonso Martín-Trejo; Laura Eugenia Espinoza-Hernández; Aurora Medina-Sanson; Luz Victoria Flores-Villegas; José Gabriel Peñaloza-González; José Refugio Torres-Nava; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Jessica Denisse Santillán-Juárez; Janet Flores-Lujano; María Luisa Pérez-Saldívar; Luis Ramiro García-López; Alejandro Castañeda-Echevarría; Francisco Rodríguez-Leyva; Haydeé Rosas-Vargas; Minerva Mata-Rocha; David Aldebarán Duarte-Rodríguez; Omar Alejandro Sepúlveda-Robles; Ismael Mancilla-Herrera; Juan Manuel Mejía-Aranguré; Mario Ernesto Cruz-Munoz Journal: PLoS One Date: 2020-01-17 Impact factor: 3.240